Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The clinical characteristics, initial presentation, management, and outcomes of patients hospitalized with new-onset (first diagnosis) heart failure (HF) or decompensation of chronic HF are poorly understood worldwide. REPORT-HF is a global, prospective, and observational HF disease registry designed to characterize patient trajectories longitudinally during and following an index hospitalization for acute HF.
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Number of patients with different characteristics of heart faliure (HF) at hospitalization | From admission to discharge of the patient's index hospitalization (minimum 24 hours) | |
| Percentage of patients who die during the index hospitalization | From admission to discharge of the patient's index hospitalization (minimum 24 hours) | |
| Percentage of patients who die during the follow-up period post-discharge | up to 3 years | |
| Percentage of patients who are re-hospitalized by primary re-hospitalization reason (Cardiovascular and non-Cardiovascular) | up to 3 years | |
| Number of patients with different characteristics of post-discharge patient management | up to 3 years | |
| Healthcare Resource Utilization assessed by number of patients with re-hospitalizations | up to 3 years |
| Measure | Description | Time Frame |
|---|---|---|
| Health-related Quality of life (HRQoL) based on patient reported data as measured by EQ-5D and the Kansas City Cardiomyopathy Questionnaire (KCCQ) questionnaires | up to 3 years | |
| Caregiver burden based on Caregiver Burden Questionnaire -Heart Failure (CBQ-HF) and Work Productivity and Activity Impairment (WPAI) questionnaires |
Not provided
Inclusion Criteria:
Patients at least 18 years old, or older for those countries where the adult age is above 18 years of age, hospitalized with a primary diagnosis of acute heart failure.
Exclusion Criteria:
1-Concomitant participation in any/a clinical trial with any investigational treatment (for any sponsor).
2. Use of investigational drugs within 5 half-lives of enrollment, or until the expected pharmacodynamic effect has returned to baseline, whichever is longer.
Not provided
Not provided
Not provided
Enrollment of adult patients hospitalized with a primary diagnosis of acute Heart Failure (HF), i.e. new-onset (first diagnosis) HF or decompensation of chronic HF
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Novartis Investigative Site | San Diego | California | 92103 | United States | ||
| Novartis Investigative Site |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 25754836 | Background | Filippatos G, Khan SS, Ambrosy AP, Cleland JG, Collins SP, Lam CS, Angermann CE, Ertl G, Dahlstrom U, Hu D, Dickstein K, Perrone SV, Ghadanfar M, Bermann G, Noe A, Schweizer A, Maier T, Gheorghiade M. International REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure (REPORT-HF): rationale for and design of a global registry. Eur J Heart Fail. 2015 May;17(5):527-33. doi: 10.1002/ejhf.262. Epub 2015 Mar 10. | |
| 41031485 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| up to 3 years |
| Correlation ratio between practice patterns and outcomes | up to 3 years |
| San Francisco |
| California |
| 94143-0780 |
| United States |
| Novartis Investigative Site | Chicago | Illinois | 60611 | United States |
| Novartis Investigative Site | Indianapolis | Indiana | 46202 | United States |
| Novartis Investigative Site | Kansas City | Kansas | 66160 | United States |
| Novartis Investigative Site | New Orleans | Louisiana | 70112 | United States |
| Novartis Investigative Site | New Orleans | Louisiana | 70121 | United States |
| Novartis Investigative Site | Detroit | Michigan | 48201 | United States |
| Novartis Investigative Site | Detroit | Michigan | 48202 | United States |
| Novartis Investigative Site | Jackson | Mississippi | 39216 | United States |
| Novartis Investigative Site | New York | New York | 10029 | United States |
| Novartis Investigative Site | Stony Brook | New York | 11794 | United States |
| Novartis Investigative Site | Cincinnati | Ohio | 45267 | United States |
| Novartis Investigative Site | Nashville | Tennessee | 37203 | United States |
| Novartis Investigative Site | Dallas | Texas | 75390 | United States |
| Novartis Investigative Site | Algiers | 16000 | Algeria |
| Novartis Investigative Site | Algiers | 16040 | Algeria |
| Novartis Investigative Site | Algiers | 16206 | Algeria |
| Novartis Investigative Site | Oran | 31000 | Algeria |
| Novartis Investigative Site | CABA | Buenos Aires | C1181ACH | Argentina |
| Novartis Investigative Site | CABA | Buenos Aires | C1210AAP | Argentina |
| Novartis Investigative Site | Buenos Aires | Buenos Aires F.D. | 1118 | Argentina |
| Novartis Investigative Site | Coronel Suarez | Buenos Aires F.D. | 7540 | Argentina |
| Novartis Investigative Site | Resistencia | Chaco Province | H3500CDM | Argentina |
| Novartis Investigative Site | Rosario | Santa Fe Province | 2000 | Argentina |
| Novartis Investigative Site | Rosario | Santa Fe Province | S2000DSV | Argentina |
| Novartis Investigative Site | Buenos Aires | C1094AAD | Argentina |
| Novartis Investigative Site | Buenos Aires | C1426EOB | Argentina |
| Novartis Investigative Site | Buenos Aires | Argentina |
| Novartis Investigative Site | Corrientes | W3400AFT | Argentina |
| Novartis Investigative Site | Córdoba | X5000JHQ | Argentina |
| Novartis Investigative Site | Córdoba | X5000 | Argentina |
| Novartis Investigative Site | Mendoza | M5500AAJ | Argentina |
| Novartis Investigative Site | Salta | 4000 | Argentina |
| Novartis Investigative Site | Gosford | New South Wales | 2250 | Australia |
| Novartis Investigative Site | Auchenflower | Queensland | 4066 | Australia |
| Novartis Investigative Site | Greenslopes | Queensland | 4120 | Australia |
| Novartis Investigative Site | Bedford Park | SA 5042 | Australia |
| Novartis Investigative Site | Eisenstadt | 7000 | Austria |
| Novartis Investigative Site | Linz | 4021 | Austria |
| Novartis Investigative Site | Mödling | A-2340 | Austria |
| Novartis Investigative Site | Vienna | A-1160 | Austria |
| Novartis Investigative Site | Vienna | A-1220 | Austria |
| Novartis Investigative Site | Fortaleza | Ceará | 60864-190 | Brazil |
| Novartis Investigative Site | Belo Horizonte | Minas Gerais | 30130-100 | Brazil |
| Novartis Investigative Site | Curitiba | Paraná | 80010-030 | Brazil |
| Novartis Investigative Site | Rio de Janeiro | Rio de Janeiro | 22280-020 | Brazil |
| Novartis Investigative Site | Campinas | São Paulo | 13060-904 | Brazil |
| Novartis Investigative Site | Tatuí | São Paulo | 18270-170 | Brazil |
| Novartis Investigative Site | Curitiba | Brazil |
| Novartis Investigative Site | Recife | Brazil |
| Novartis Investigative Site | Rio de Janeiro | Brazil |
| Novartis Investigative Site | Sao Jose Do Rico Preto | Brazil |
| Novartis Investigative Site | Pleven | 5800 | Bulgaria |
| Novartis Investigative Site | Plovdiv | 4002 | Bulgaria |
| Novartis Investigative Site | Sofia | 1202 | Bulgaria |
| Novartis Investigative Site | Sofia | 1527 | Bulgaria |
| Novartis Investigative Site | Sofia | 1606 | Bulgaria |
| Novartis Investigative Site | Varna | 9010 | Bulgaria |
| Novartis Investigative Site | Edmonton | Alberta | T6G 2B7 | Canada |
| Novartis Investigative Site | Vancouver | British Columbia | V6Z 1Y6 | Canada |
| Novartis Investigative Site | Halifax | Nova Scotia | B3H 3A7 | Canada |
| Novartis Investigative Site | Ottawa | Ontario | K1Y 4W7 | Canada |
| Novartis Investigative Site | Sainte-Foy | Quebec | G1V 4G5 | Canada |
| Novartis Investigative Site | San Miguel | Santiago Metropolitan | 8900000 | Chile |
| Novartis Investigative Site | Concepción | Chile |
| Novartis Investigative Site | Santiago | Piso 1 | Chile |
| Novartis Investigative Site | Santiago | Chile |
| Novartis Investigative Site | Beijing | Beijing Municipality | 100044 | China |
| Novartis Investigative Site | Beijing | Beijing Municipality | 100191 | China |
| Novartis Investigative Site | Fuzhou | Fujian | China |
| Novartis Investigative Site | Guangzhou | Guangdong | 510080 | China |
| Novartis Investigative Site | Shijiazhuang | Hebei | 050000 | China |
| Novartis Investigative Site | Wuhan | Hubei | 430074 | China |
| Novartis Investigative Site | Changsha | Hunan | 410005 | China |
| Novartis Investigative Site | Changsha | Hunan | 410011 | China |
| Novartis Investigative Site | Baotou | Inner Mongolia | 014040 | China |
| Novartis Investigative Site | Changchun | Jilin | 130021 | China |
| Novartis Investigative Site | Dalian | Liaoning | 116011 | China |
| Novartis Investigative Site | Beijing | 100022 | China |
| Novartis Investigative Site | Beijing | 100029 | China |
| Novartis Investigative Site | Beijing | 100034 | China |
| Novartis Investigative Site | Beijing | 100053 | China |
| Novartis Investigative Site | Beijing | China |
| Novartis Investigative Site | Guangzhou | 510260 | China |
| Novartis Investigative Site | Hangzhou | 310006 | China |
| Novartis Investigative Site | Jinan | 250012 | China |
| Novartis Investigative Site | Luoyang | 471000 | China |
| Novartis Investigative Site | Shanghai | 200080 | China |
| Novartis Investigative Site | Taiyuan | China |
| Novartis Investigative Site | Ürümqi | 830000 | China |
| Novartis Investigative Site | Ürümqi | 830054 | China |
| Novartis Investigative Site | Wuhan | 430022 | China |
| Novartis Investigative Site | Xiamen | 361004 | China |
| Novartis Investigative Site | Yangzhou | 225001 | China |
| Novartis Investigative Site | Zhengzhou | 450003 | China |
| Novartis Investigative Site | Zhengzhou | China |
| Novartis Investigative Site | Medellín | Antioquia | 0050010 | Colombia |
| Novartis Investigative Site | Medellín | Antioquia | Colombia |
| Novartis Investigative Site | Barranquilla | Atlántico | Colombia |
| Novartis Investigative Site | Bogotá | Cundinamarca | 110111 | Colombia |
| Novartis Investigative Site | Bucaramanga | Santander Department | Colombia |
| Novartis Investigative Site | Armenia | Colombia |
| Novartis Investigative Site | Bogotá | 00000 | Colombia |
| Novartis Investigative Site | Bogotá | Colombia |
| Novartis Investigative Site | Cali | Colombia |
| Novartis Investigative Site | Guayaquil | Guayas | Ecuador |
| Novartis Investigative Site | Quito | Pichincha | 1701 | Ecuador |
| Novartis Investigative Site | Guayaquil | Ecuador |
| Novartis Investigative Site | Portoviejo | Ecuador |
| Novartis Investigative Site | Alexandria | 21411 | Egypt |
| Novartis Investigative Site | Cairo | 11566 | Egypt |
| Novartis Investigative Site | Cairo | Egypt |
| Novartis Investigative Site | El Menia, Upper Egypt | Egypt |
| Novartis Investigative Site | Suez Canal Region | 41111 | Egypt |
| Novartis Investigative Site | Berlin | 13353 | Germany |
| Novartis Investigative Site | Bonn | 53105 | Germany |
| Novartis Investigative Site | Essen | 45356 | Germany |
| Novartis Investigative Site | Freiburg im Breisgau | 79106 | Germany |
| Novartis Investigative Site | Göttingen | 37075 | Germany |
| Novartis Investigative Site | Halle | 06120 | Germany |
| Novartis Investigative Site | Hanover | 30625 | Germany |
| Novartis Investigative Site | Heidelberg | 69120 | Germany |
| Novartis Investigative Site | Homburg | 66421 | Germany |
| Novartis Investigative Site | Ludwigshafen | 67063 | Germany |
| Novartis Investigative Site | Lübeck | 23538 | Germany |
| Novartis Investigative Site | Nuremberg | 90471 | Germany |
| Novartis Investigative Site | Würzburg | 97078 | Germany |
| Novartis Investigative Site | Athens | GR | 115 25 | Greece |
| Novartis Investigative Site | Athens | GR | 115 27 | Greece |
| Novartis Investigative Site | Athens | GR | 11527 | Greece |
| Novartis Investigative Site | Thessaloniki | GR | 570 10 | Greece |
| Novartis Investigative Site | Athens | 11526 | Greece |
| Novartis Investigative Site | Athens | 54642 | Greece |
| Novartis Investigative Site | Athens | GR 115 22 | Greece |
| Novartis Investigative Site | Glyfada | 16675 | Greece |
| Novartis Investigative Site | Ioannina | 45100 | Greece |
| Novartis Investigative Site | Piraeus | 18454 | Greece |
| Novartis Investigative Site | Thessaloniki | 54642 | Greece |
| Novartis Investigative Site | Guatemala City | 01011 | Guatemala |
| Novartis Investigative Site | Guatemala City | Guatemala |
| Novartis Investigative Site | Panjim | Goa | 403001 | India |
| Novartis Investigative Site | Ahmedabad | Gujarat | 380 060 | India |
| Novartis Investigative Site | Vadodara | Gujarat | 390022 | India |
| Novartis Investigative Site | Gurgaon | Haryana | 122001 | India |
| Novartis Investigative Site | Bangalore | Karnataka | 560 069 | India |
| Novartis Investigative Site | Bangalore | Karnataka | 560099 | India |
| Novartis Investigative Site | Manipal | Karnataka | 576104 | India |
| Novartis Investigative Site | Nagpur | Maharashtra | 440008 | India |
| Novartis Investigative Site | Pune | Maharashtra | 411 011 | India |
| Novartis Investigative Site | Pune | Maharashtra | 411011 | India |
| Novartis Investigative Site | New Delhi | National Capital Territory of Delhi | 110 060 | India |
| Novartis Investigative Site | New Delhi | National Capital Territory of Delhi | 110017 | India |
| Novartis Investigative Site | New Delhi | National Capital Territory of Delhi | 110070 | India |
| Novartis Investigative Site | Amritsar | Punjab | 143004 | India |
| Novartis Investigative Site | Ludhiana | Punjab | 141001 | India |
| Novartis Investigative Site | Ludhiana | Punjab | 141008 | India |
| Novartis Investigative Site | Chennai | Tamil Nadu | 600037 | India |
| Novartis Investigative Site | Hyderabad | Telangana | 500034 | India |
| Novartis Investigative Site | Hyderabad | Telangana | 500082 | India |
| Novartis Investigative Site | Kolkata | West Bengal | 700 107 | India |
| Novartis Investigative Site | Kolkata | West Bengal | 700099 | India |
| Novartis Investigative Site | India | 560040 | India |
| Novartis Investigative Site | Mumbai | 400053 | India |
| Novartis Investigative Site | New Delhi | 110002 | India |
| Novartis Investigative Site | New Delhi | 110025 | India |
| Novartis Investigative Site | Tangerang | Banten | 15111 | Indonesia |
| Novartis Investigative Site | East Jakarta | DKI Jakarta | 13630 | Indonesia |
| Novartis Investigative Site | South Jakarta | DKI Jakarta | 12430 | Indonesia |
| Novartis Investigative Site | West Jakarta | DKI Jakarta | 11420 | Indonesia |
| Novartis Investigative Site | Surabaya | East Java | 60286 | Indonesia |
| Novartis Investigative Site | Medan | North Sumatera | 20136 | Indonesia |
| Novartis Investigative Site | Bandung | West Java | 40161 | Indonesia |
| Novartis Investigative Site | Bekasi | West Java | 17144 | Indonesia |
| Novartis Investigative Site | Padang | West Sumatra | 25127 | Indonesia |
| Novartis Investigative Site | Jerusalem | 91031 | Israel |
| Novartis Investigative Site | Jerusalem | 91240 | Israel |
| Novartis Investigative Site | Kfar Saba | 4428164 | Israel |
| Novartis Investigative Site | Nazareth | 16100 | Israel |
| Novartis Investigative Site | Sefad | 13100 | Israel |
| Novartis Investigative Site | Kitakyushu | Fukuoka | 802-8555 | Japan |
| Novartis Investigative Site | Kure | Hiroshima | 737-0023 | Japan |
| Novartis Investigative Site | Sakaidechō | Kagawa-ken | 762-0007 | Japan |
| Novartis Investigative Site | Kita-ku | Okayama-ken | 7000084 | Japan |
| Novartis Investigative Site | Hirakata | Osaka | 573-0153 | Japan |
| Novartis Investigative Site | Chiyoda-ku | Tokyo | 101-8643 | Japan |
| Novartis Investigative Site | Nagasaki | 850-8555 | Japan |
| Novartis Investigative Site | Amman | 11121 | Jordan |
| Novartis Investigative Site | Amman | 11196 | Jordan |
| Novartis Investigative Site | Amman | 11942 | Jordan |
| Novartis Investigative Site | Amman | Jordan |
| Novartis Investigative Site | Irbid | 22110 | Jordan |
| Novartis Investigative Site | El Chouf | LBN | Lebanon |
| Novartis Investigative Site | Beirut | 1107 2020 | Lebanon |
| Novartis Investigative Site | Beirut | 6301 | Lebanon |
| Novartis Investigative Site | Beirut | Lebanon |
| Novartis Investigative Site | Byblos | Lebanon |
| Novartis Investigative Site | Saida | 652 | Lebanon |
| Novartis Investigative Site | Alor Star | Kedah | 05460 | Malaysia |
| Novartis Investigative Site | Kota Bharu | Kelantan | 16150 | Malaysia |
| Novartis Investigative Site | Pulau Pinang | Pulau Pinang | 10990 | Malaysia |
| Novartis Investigative Site | Johor Bahru | 80100 | Malaysia |
| Novartis Investigative Site | Kuala Lumpur | 50586 | Malaysia |
| Novartis Investigative Site | Mexico City | Mexico City | 03100 | Mexico |
| Novartis Investigative Site | Mexico City | Mexico City | 06090 | Mexico |
| Novartis Investigative Site | Mexico City | Mexico City | 14080 | Mexico |
| Novartis Investigative Site | Culiacán | Sinaloa SN | 80230 | Mexico |
| Novartis Investigative Site | Aguascalientes | 20230 | Mexico |
| Novartis Investigative Site | San Luis Potosí City | 78213 | Mexico |
| Novartis Investigative Site | San Luis Potosí City | 78240 | Mexico |
| Novartis Investigative Site | Xalapa | 91020 | Mexico |
| Novartis Investigative Site | Xalapa | 91193 | Mexico |
| Novartis Investigative Site | Casablanca | Morocco |
| Novartis Investigative Site | Marrakesh | 40 000 | Morocco |
| Novartis Investigative Site | Rabat | 10 000 | Morocco |
| Novartis Investigative Site | Amsterdam | 1034CS | Netherlands |
| Novartis Investigative Site | Groningen | 9713 GZ | Netherlands |
| Novartis Investigative Site | Leiderdorp | NL-2353 GA | Netherlands |
| Novartis Investigative Site | Sneek | 8601ZK | Netherlands |
| Novartis Investigative Site | Venlo | 5912 BL | Netherlands |
| Novartis Investigative Site | Zwolle | 8025 AB | Netherlands |
| Novartis Investigative Site | Hønefoss | 3501 | Norway |
| Novartis Investigative Site | Oslo | 370 | Norway |
| Novartis Investigative Site | Skien | NO-3710 | Norway |
| Novartis Investigative Site | San Jose de David | Provincia de Panamá | Panama |
| Novartis Investigative Site | Panama City | Panama |
| Novartis Investigative Site | Baguio City | Baguio | 2600 | Philippines |
| Novartis Investigative Site | Cagayan de Oro City | Cagayan Valley | 9000 | Philippines |
| Novartis Investigative Site | Cebu City | Cebu | 6000 | Philippines |
| Novartis Investigative Site | Davao City | Davao Region | 8000 | Philippines |
| Novartis Investigative Site | Quezon City | Manila | 1100 | Philippines |
| Novartis Investigative Site | Manila | National Capital Region | 1000 | Philippines |
| Novartis Investigative Site | Angeles City | Pampanga | 2009 | Philippines |
| Novartis Investigative Site | Cluj-Napoca | Napoca | 400006 | Romania |
| Novartis Investigative Site | Bucharest | 022322 | Romania |
| Novartis Investigative Site | Bucharest | 030 171 | Romania |
| Novartis Investigative Site | Buzău | 120140 | Romania |
| Novartis Investigative Site | Cluj-Napoca | 400006 | Romania |
| Novartis Investigative Site | Focşani | 620034 | Romania |
| Novartis Investigative Site | Lasi | 700075 | Romania |
| Novartis Investigative Site | Timișoara | 300054 | Romania |
| Novartis Investigative Site | Kazan' | 420033 | Russia |
| Novartis Investigative Site | Kemerovo | 654005 | Russia |
| Novartis Investigative Site | Krasnodar | 350086 | Russia |
| Novartis Investigative Site | Moscow | 117292 | Russia |
| Novartis Investigative Site | Moscow | 127473 | Russia |
| Novartis Investigative Site | Novosibirsk | 630091 | Russia |
| Novartis Investigative Site | Ryazan | 390026 | Russia |
| Novartis Investigative Site | S-Petersburg | 194354 | Russia |
| Novartis Investigative Site | Saint Petersburg | 191015 | Russia |
| Novartis Investigative Site | Saint Petersburg | 194044 | Russia |
| Novartis Investigative Site | Saint Petersburg | 197341 | Russia |
| Novartis Investigative Site | Saratov | 410004 | Russia |
| Novartis Investigative Site | Saratov | 410017 | Russia |
| Novartis Investigative Site | Stavropol | 355030 | Russia |
| Novartis Investigative Site | Tyumen | 625023 | Russia |
| Novartis Investigative Site | Ulyanovsk | 432057 | Russia |
| Novartis Investigative Site | Vladivostok | 690002 | Russia |
| Novartis Investigative Site | Volgograd | 400026 | Russia |
| Novartis Investigative Site | Al Ahsa | Saudi Arabia |
| Novartis Investigative Site | Dammam | 15215 | Saudi Arabia |
| Novartis Investigative Site | Dammam | 31463 | Saudi Arabia |
| Novartis Investigative Site | Khamis Mushait | 62413 | Saudi Arabia |
| Novartis Investigative Site | Riyadh | 3643 | Saudi Arabia |
| Novartis Investigative Site | Durban | KwaZulu-Natal | 4052 | South Africa |
| Novartis Investigative Site | Bloemfontein | 9301 | South Africa |
| Novartis Investigative Site | Cape Town | 7405 | South Africa |
| Novartis Investigative Site | Cape Town | 7505 | South Africa |
| Novartis Investigative Site | Rivonia | 2128 | South Africa |
| Novartis Investigative Site | Gyeonggi-do | Bucheon-si | 422-711 | South Korea |
| Novartis Investigative Site | Wŏnju | Gangwon-do | 220-701 | South Korea |
| Novartis Investigative Site | Daejeon | Korea | 301-721 | South Korea |
| Novartis Investigative Site | Cheongju-si | North Chungcheong | 28644 | South Korea |
| Novartis Investigative Site | Busan | 612-896 | South Korea |
| Novartis Investigative Site | Incheon | 403-720 | South Korea |
| Novartis Investigative Site | Pusan | 614-735 | South Korea |
| Novartis Investigative Site | Seoul | 07061 | South Korea |
| Novartis Investigative Site | Seoul | 136-705 | South Korea |
| Novartis Investigative Site | Suwon | 16247 | South Korea |
| Novartis Investigative Site | Taegu | 700 -721 | South Korea |
| Novartis Investigative Site | Mallorca | Balearic Islands | 07198 | Spain |
| Novartis Investigative Site | Barakaldo | Basque Country | 48903 | Spain |
| Novartis Investigative Site | Barcelona | Catalonia | 08035 | Spain |
| Novartis Investigative Site | Barcelona | Catalonia | 08036 | Spain |
| Novartis Investigative Site | Tarragona | Catalonia | 43005 | Spain |
| Novartis Investigative Site | Mérida | Extremadura | 06800 | Spain |
| Novartis Investigative Site | Las Palmas de Gran Canaria | Las Palmas de G.C | 35020 | Spain |
| Novartis Investigative Site | Majadahonda | Madrid | 28222 | Spain |
| Novartis Investigative Site | Alicante | Valencia | 03010 | Spain |
| Novartis Investigative Site | Barcelona | 08041 | Spain |
| Novartis Investigative Site | Córdoba | Spain |
| Novartis Investigative Site | León | 24080 | Spain |
| Novartis Investigative Site | Murcia | 30008 | Spain |
| Novartis Investigative Site | Gothenburg | 416 85 | Sweden |
| Novartis Investigative Site | Helsingborg | 252 20 | Sweden |
| Novartis Investigative Site | Karlshamn | 37480 | Sweden |
| Novartis Investigative Site | Linköping | 581 85 | Sweden |
| Novartis Investigative Site | Malmö | 205 20 | Sweden |
| Novartis Investigative Site | Trollhättan | 46173 | Sweden |
| Novartis Investigative Site | Basel | 4031 | Switzerland |
| Novartis Investigative Site | Bruderholz | 4101 | Switzerland |
| Novartis Investigative Site | Zurich | 8032 | Switzerland |
| Novartis Investigative Site | Linkou District | 33305 | Taiwan |
| Novartis Investigative Site | Taichung | 40705 | Taiwan |
| Novartis Investigative Site | Tainan | 70421 | Taiwan |
| Novartis Investigative Site | Taipei | 10002 | Taiwan |
| Novartis Investigative Site | Taipei | 110 | Taiwan |
| Novartis Investigative Site | Taipei | 11217 | Taiwan |
| Novartis Investigative Site | Muang | Muang | 65000 | Thailand |
| Novartis Investigative Site | Muang | Thailand | 12120 | Thailand |
| Novartis Investigative Site | Muang | Thailand | 30000 | Thailand |
| Novartis Investigative Site | Khon Kaen | THA | 40002 | Thailand |
| Novartis Investigative Site | Bangkok | 10310 | Thailand |
| Novartis Investigative Site | Bangkok | 10400 | Thailand |
| Novartis Investigative Site | Chiang Mai | 50200 | Thailand |
| Novartis Investigative Site | Monastir | 5000 | Tunisia |
| Novartis Investigative Site | Sousse | 4011 | Tunisia |
| Novartis Investigative Site | Tunis | 1006 | Tunisia |
| Novartis Investigative Site | Tunis | 1007 | Tunisia |
| Novartis Investigative Site | Tunis | 1008 | Tunisia |
| Novartis Investigative Site | Pendik / Istanbul | Turkey | 34899 | Turkey (Türkiye) |
| Novartis Investigative Site | Ankara | 06100 | Turkey (Türkiye) |
| Novartis Investigative Site | Ankara | 06590 | Turkey (Türkiye) |
| Novartis Investigative Site | Bursa | 16059 | Turkey (Türkiye) |
| Novartis Investigative Site | Bursa | Turkey (Türkiye) |
| Novartis Investigative Site | Diskapi / Ankara | 06110 | Turkey (Türkiye) |
| Novartis Investigative Site | Haydarpasa/Istanbul | 34668 | Turkey (Türkiye) |
| Novartis Investigative Site | Istanbul | 34093 | Turkey (Türkiye) |
| Novartis Investigative Site | Meselik / Eskisehir | 26480 | Turkey (Türkiye) |
| Novartis Investigative Site | Sivas | 58140 | Turkey (Türkiye) |
| Novartis Investigative Site | Abu Dhabi | 51900 | United Arab Emirates |
| Novartis Investigative Site | Al Ain City | United Arab Emirates |
| Novartis Investigative Site | Dubai | 7272 | United Arab Emirates |
| Novartis Investigative Site | Dubai | United Arab Emirates |
| Novartis Investigative Site | Edgbaston | Birmingham | B15 2WB | United Kingdom |
| Novartis Investigative Site | Stockton-on-Tees | Cleveland | TS19 8PE | United Kingdom |
| Novartis Investigative Site | Bradford | West Yorkshire | BD9 6RJ | United Kingdom |
| Novartis Investigative Site | Chesterfield | Yorkshire | S44 5BL | United Kingdom |
| Novartis Investigative Site | Herts | Yorkshire | SG1 4AB | United Kingdom |
| Novartis Investigative Site | Chesterfield | BS1 3NU | United Kingdom |
| Novartis Investigative Site | Telford | TF1 6TF | United Kingdom |
| Novartis Investigative Site | Uxbridge | UB8 3NN | United Kingdom |
| Novartis Investigative Site | Wakefield | WF1 4DG | United Kingdom |
| Novartis Investigative Site | York | YO31 8HE | United Kingdom |
| Novartis Investigative Site | Ho Chi Minh City | District 7 | Vietnam |
| Novartis Investigative Site | Ho Chi Minh City | Vietnam |
| Derived |
| Tay WT, Teng TK, Ouwerkerk W, Cleland JGF, Collins SP, Angermann CE, Dickstein K, Dahlstrom U, Schweizer A, Obergfell A, Yiu KH, Ghadanfar M, Hassanein M, Ren QW, Gu WL, Ertl G, Perrone SV, Filippatos G, Lam CSP, Tromp J. Global patterns of polypharmacy after acute heart failure hospitalization: Prevalence and outcomes from the REPORT-HF registry. Eur J Heart Fail. 2025 Dec;27(12):2705-2715. doi: 10.1002/ejhf.70056. Epub 2025 Oct 1. |
| 39918534 | Derived | Chyou JY, Tay WT, Tromp J, Ouwerkerk W, Yiu KH, Cleland JGF, Collins SP, Angermann CE, Ertl G, Dahlstrom U, Dickstein K, Perrone SV, Ghadanfar M, Schweizer A, Obergfell A, Filippatos G, Lam CSP. Prognostic Implications and Global Perspectives of Atrial Fibrillation in Patients Hospitalized for Heart Failure. JACC Heart Fail. 2025 Mar;13(3):453-464. doi: 10.1016/j.jchf.2024.11.009. Epub 2025 Feb 5. |
| 36196060 | Derived | Ouwerkerk W, Tromp J, Cleland JGF, Angermann CE, Dahlstrom U, Ertl G, Hassanein M, Perrone SV, Ghadanfar M, Schweizer A, Obergfell A, Dickstein K, Filippatos G, Collins SP, Lam CSP. Association of time-to-intravenous furosemide with mortality in acute heart failure: data from REPORT-HF. Eur J Heart Fail. 2023 Jan;25(1):43-51. doi: 10.1002/ejhf.2708. Epub 2022 Nov 23. |
| ID | Term |
|---|---|
| D006333 | Heart Failure |
| ID | Term |
|---|---|
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided